Earlier OST Involvement In Device Lifecycle Is Potential User Fee Impact
This article was originally published in The Gray Sheet
Executive Summary
Medical device user fees could spur the Office of Science & Technology to become involved with reviews earlier in the device lifecycle, CDRH topsiders suggest
You may also be interested in...
FDA Extra FY 2003 Funding, User Fee Program Launch A Given – Industry
FDA will receive the additional $15 mil. in funding that it needs in FY 2003 to implement the just-passed device user fee legislation, the medical device industry expects
Device Center To Add Program For Joint Planning Of PMA Submissions
The Center for Devices and Radiological Health is planning to offer a new type of meeting in which sponsors and FDA reviewers agree on content and format of a premarket application submission
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.